A complete reference on the peptides used to study tissue repair and recovery — cytoprotective and angiogenic signaling, actin-dependent cell migration, extracellular-matrix remodeling, and anti-inflammatory pathways — with mechanisms, specifications, key literature, and per-lot-verified research reagents.
Tissue repair is a coordinated, multi-stage process — hemostasis, inflammation, proliferation, and remodeling. Research peptides in this area act as tools to probe specific stages of that cascade.
Two compounds dominate the regenerative-research literature: BPC-157, a stable gastric pentadecapeptide studied for cytoprotection and angiogenesis, and TB-500, the synthetic fragment of thymosin β4 studied for actin regulation and cell migration. They engage different but complementary mechanisms, which is why they appear together in so many repair-model studies.[1][2]
Research framing only · No therapeutic, dosing, or human-use claims
02Angiogenesis & Cytoprotection
The proliferative phase of repair depends on angiogenesis — the formation of new blood vessels to supply a healing site. Compounds that promote angiogenic signaling in model systems are central tools for studying this stage.[1]
BPC-157 is the most-studied peptide in this category. Derived from a protective protein found in gastric juice, it is investigated for cytoprotection across many tissue types and for up-regulation of the VEGFR2 pathway that drives new-vessel formation — a mechanism proposed to underlie its broad effects in tendon, ligament, gut, and other repair models.[1][3]
03Actin Regulation & ECM Remodeling
Cell migration — moving repair cells into a wound — depends on the actin cytoskeleton, and the remodeling phase depends on rebuilding the extracellular matrix (ECM). Different peptides engage each.
Tool
Mechanism class
Primary research interest
BPC-157
Cytoprotective / angiogenic
VEGFR2 signaling; tendon, ligament, gut repair models
TB-500
Actin-regulating (Tβ4 fragment)
Cell migration; angiogenesis; cardiac and muscle repair
NF-κB pathway; mucosal and inflammatory-repair models
BPC-157Cytoprotective / Angiogenic
BPC-157 is a stable synthetic pentadecapeptide (15 amino acids) derived from a protective protein sequence found in gastric juice. It is the single most-studied peptide in regenerative research.[1]
What researchers study
BPC-157 is investigated for cytoprotection and angiogenesis across a wide range of tissue-repair models — tendon, ligament, muscle, and gastrointestinal — with its effects attributed in part to up-regulation of the VEGFR2 pathway that drives new blood-vessel formation.[1][3]
Specifications
Class
Synthetic gastric pentadecapeptide
Molecular weight
1,419.5 g/mol
Form
Lyophilized powder
Purity
≥99% (HPLC, MS-verified)
Available
5 · 10 mg
TB-500Actin-Regulating
TB-500 is a synthetic version of the active region of thymosin β4, a naturally occurring peptide that regulates actin — the protein essential to cell structure and movement.[2]
What researchers study
TB-500 is studied for its role in cell migration, angiogenesis, and tissue regeneration. By binding actin and promoting its regulation, it is investigated in cardiac, muscle, and wound-repair models, frequently alongside BPC-157 for complementary mechanisms.[2]
Specifications
Class
Synthetic thymosin β4 fragment
Molecular weight
4,963.4 g/mol
Form
Lyophilized powder
Purity
≥99% (HPLC, MS-verified)
Available
5 · 10 mg
GHK-CuCopper Tripeptide
GHK-Cu is a naturally occurring copper-binding tripeptide whose plasma level declines with age. It is one of the most-cited peptides in wound-healing and tissue-remodeling research.[4]
What researchers study
GHK-Cu is investigated for collagen and extracellular-matrix synthesis, activation of wound-healing gene programs, and antioxidant signaling — making it a key tool for the remodeling phase of tissue-repair research.[4]
Specifications
Class
Copper-binding tripeptide (GHK-Cu)
Molecular weight
404.92 g/mol
Form
Lyophilized powder
Purity
≥99% (HPLC, MS-verified)
Available
50 · 100 mg
KPVAnti-Inflammatory
KPV is a tripeptide (lysine-proline-valine) corresponding to the C-terminal active fragment of α-melanocyte-stimulating hormone (α-MSH), which retains the parent hormone's anti-inflammatory activity.[5]
What researchers study
KPV is studied for anti-inflammatory signaling, including inhibition of the NF-κB pathway, and is investigated in mucosal and inflammatory-repair models where resolution of inflammation is the rate-limiting step in recovery.[5]
Specifications
Class
α-MSH(11–13) tripeptide
Molecular weight
342.4 g/mol
Form
Lyophilized powder
Purity
≥99% (HPLC, MS-verified)
Available
5 mg
08Supporting Compounds
Beyond the core repair tools, several immune-modulating and regenerative peptides appear together in comprehensive tissue-recovery research.
A practical view of the core reagents in this guide — class, vial range, and entry price — to help researchers scope a study budget. Larger vials carry a lower per-milligram cost.
Compound
Class
Vial range
From
Best value vial
BPC-157
Cytoprotective
5–10 mg
$49.99
10 mg — $89.99 ($9.00/mg)
TB-500
Actin regulator
5–10 mg
$64.99
10 mg — $116.99 ($11.70/mg)
GHK-Cu
Copper tripeptide
50–100 mg
$54.99
100 mg — $94.99 ($0.95/mg)
KPV
Anti-inflammatory
5–10 mg
$39.99
10 mg — $64.99 ($6.50/mg)
10Handling, Reconstitution & Storage
These are general handling notes for lyophilized peptide reagents in a laboratory setting — not use instructions of any kind.
Storage
Lyophilized (freeze-dried) peptides are most stable as a dry powder. Stored at −4°F and protected from light and moisture, they remain stable for extended periods. Vials should be allowed to reach room temperature before opening to avoid condensation on the powder.
Reconstitution
For laboratory work, peptides are typically reconstituted with bacteriostatic or sterile water added slowly against the vial wall, then swirled — not shaken — until fully dissolved. Reconstituted peptide is kept refrigerated at 36–46°F and used within the window established by the researcher's protocol.
Handling notes for laboratory reagents only · Not directions for human or veterinary use
11Purity & Verification
Every Ethos Bio lot is analyzed by reverse-phase HPLC and independently confirmed by mass spectrometry through our third-party partner, Janoshik Analytical. A signed Certificate of Analysis documenting identity and ≥99% purity is provided for every lot and mirrored to your researcher account.
Every lot, independently verified
Identity by mass spectrometry, purity by HPLC. The COA shipped with your order reflects your specific lot.
They engage complementary mechanisms: BPC-157 is studied for cytoprotection and angiogenesis (new blood-vessel formation), while TB-500 is studied for actin regulation and cell migration. Together they cover different stages of the tissue-repair cascade, which is why they appear in many repair-model studies as a pair.
What is angiogenesis and why does it matter in repair research?
Angiogenesis is the formation of new blood vessels. During the proliferative phase of tissue repair, new vessels supply oxygen and nutrients to the healing site. Compounds studied for angiogenic signaling, like BPC-157, are central tools for this stage of repair research.
What does KPV do differently from the regenerative peptides?
KPV is studied for anti-inflammatory signaling — it engages pathways like NF-κB that govern the resolution of inflammation, an earlier stage of repair than the proliferative and remodeling work of BPC-157, TB-500, and GHK-Cu.
Are these compounds healing or recovery treatments?
No. Every compound listed is supplied strictly as a research reagent for laboratory and animal-model study. Nothing here is for human consumption, and no healing, recovery, or therapeutic claims are made.
How is purity verified?
Every Ethos Bio lot is analyzed by reverse-phase HPLC and independently confirmed by mass spectrometry, with a per-lot Certificate of Analysis documenting identity and ≥99% purity.
13References
Sikiric P, Seiwerth S, Rucman R, et al. Stable gastric pentadecapeptide BPC 157 in trials for inflammatory bowel disease. Current Pharmaceutical Design. 2011;17(16):1612–1632.
Goldstein AL, Hannappel E, Sosne G, Kleinman HK. Thymosin β4: a multi-functional regenerative peptide. Expert Opinion on Biological Therapy. 2012;12(1):37–51.
Hsieh MJ, Liu HT, Wang CN, et al. Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation. Journal of Molecular Medicine. 2017;95(3):323–333.
Pickart L, Margolina A. Regenerative and protective actions of the GHK-Cu peptide. International Journal of Molecular Sciences. 2018;19(7):1987.
References are provided for scientific context on the receptor pathways discussed. Citation of a study does not constitute a therapeutic claim about any Ethos Bio product, all of which are sold for Research Use Only.
